These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26580477)

  • 61. Recent advances of siRNA delivery by nanoparticles.
    Yuan X; Naguib S; Wu Z
    Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nanocapsules for Drug Delivery: An Updated Review of the Last Decade.
    Erdoğar N; Akkın S; Bilensoy E
    Recent Pat Drug Deliv Formul; 2018; 12(4):252-266. PubMed ID: 30674269
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain.
    Kasongo KW; Jansch M; Müller RH; Walker RB
    J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Self-assembly of drug-loaded liposomes on genetically engineered target-recognizing M13 phage: a novel nanocarrier for targeted drug delivery.
    Ngweniform P; Abbineni G; Cao B; Mao C
    Small; 2009 Sep; 5(17):1963-9. PubMed ID: 19415651
    [No Abstract]   [Full Text] [Related]  

  • 65. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rational Design of Nanocarriers for Intracellular Protein Delivery.
    Qin X; Yu C; Wei J; Li L; Zhang C; Wu Q; Liu J; Yao SQ; Huang W
    Adv Mater; 2019 Nov; 31(46):e1902791. PubMed ID: 31496027
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liposomal nanostructures for photosensitizer delivery.
    Jin CS; Zheng G
    Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nanotechnology applied to the treatment of malaria.
    Santos-Magalhães NS; Mosqueira VC
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):560-75. PubMed ID: 19914313
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Controlled delivery of peptides and proteins.
    Degim IT; Celebi N
    Curr Pharm Des; 2007; 13(1):99-117. PubMed ID: 17266590
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein-based nanoparticles: From preparation to encapsulation of active molecules.
    Tarhini M; Greige-Gerges H; Elaissari A
    Int J Pharm; 2017 Apr; 522(1-2):172-197. PubMed ID: 28188876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In situ synthesis and photoresponsive rupture of organosilica nanocapsules.
    Hayashi K; Nakamura M; Ishimura K
    Chem Commun (Camb); 2011 Feb; 47(5):1518-20. PubMed ID: 21103535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lipid-based carriers for pulmonary products: preclinical development and case studies in humans.
    Cipolla D; Shekunov B; Blanchard J; Hickey A
    Adv Drug Deliv Rev; 2014 Aug; 75():53-80. PubMed ID: 24819218
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nanonization strategies for poorly water-soluble drugs.
    Chen H; Khemtong C; Yang X; Chang X; Gao J
    Drug Discov Today; 2011 Apr; 16(7-8):354-60. PubMed ID: 20206289
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protein-based nanocarriers as promising drug and gene delivery systems.
    Elzoghby AO; Samy WM; Elgindy NA
    J Control Release; 2012 Jul; 161(1):38-49. PubMed ID: 22564368
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carrier mediated protein and peptide stabilization.
    Tiwari AK; Gajbhiye V; Sharma R; Jain NK
    Drug Deliv; 2010 Nov; 17(8):605-16. PubMed ID: 20879837
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
    Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
    Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.